Selected research
Industry Growth & Trends
Global Automatic Insulin Dose Adjustment Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Automatic Insulin Dose Adjustment Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Automatic Insulin Dose Adjustment Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Automatic Insulin Dose Adjustment Software market include Glytec, Beta Bionics, Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod and Tempo Platform, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Automatic Insulin Dose Adjustment Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Automatic Insulin Dose Adjustment Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Automatic Insulin Dose Adjustment Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Automatic Insulin Dose Adjustment Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Automatic Insulin Dose Adjustment Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Automatic Insulin Dose Adjustment Software Market by Company
Glytec
Beta Bionics
Hygieia
Tandem Diabetics
CamDiab
Medtronic
Novo Nordisk
Omnipod
Tempo Platform
Automatic Insulin Dose Adjustment Software Segment by Type
Open-Loop Systems
Closed-Loop Systems
Automatic Insulin Dose Adjustment Software Segment by Application
Subscription Used
One-time Purchase Used
Automatic Insulin Dose Adjustment Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Automatic Insulin Dose Adjustment Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Automatic Insulin Dose Adjustment Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Automatic Insulin Dose Adjustment Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Automatic Insulin Dose Adjustment Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Open-Loop Systems
- Closed-Loop Systems
Applications
- Subscription Used
- One-time Purchase Used
Companies covered
- Glytec
- Beta Bionics
- Hygieia
- Tandem Diabetics
- CamDiab
- Medtronic
- Novo Nordisk
- Omnipod
- Tempo Platform
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Automatic Insulin Dose Adjustment Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Automatic Insulin Dose Adjustment Software Market Size by Region (2021-2032)
- 1.4.1 Global Automatic Insulin Dose Adjustment Software Market Size by Region (2021-2026)
- 1.4.2 Global Automatic Insulin Dose Adjustment Software Market Size by Region (2027-2032)
- 1.5 Key Regions Automatic Insulin Dose Adjustment Software Market Size (2021-2032)
- 1.5.1 North America Automatic Insulin Dose Adjustment Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Automatic Insulin Dose Adjustment Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Automatic Insulin Dose Adjustment Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size Growth Rate (2021-2032)
2 Automatic Insulin Dose Adjustment Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Open-Loop Systems
- 2.1.2 Closed-Loop Systems
- 2.2 Global Automatic Insulin Dose Adjustment Software Market Size by Type
- 2.2.1 Global Automatic Insulin Dose Adjustment Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Automatic Insulin Dose Adjustment Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Automatic Insulin Dose Adjustment Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Automatic Insulin Dose Adjustment Software Market Size by Regions
- 2.3.1 North America Automatic Insulin Dose Adjustment Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Automatic Insulin Dose Adjustment Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Automatic Insulin Dose Adjustment Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Automatic Insulin Dose Adjustment Software Market Size Breakdown by Type (2021-2026)
3 Automatic Insulin Dose Adjustment Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Subscription Used
- 3.1.2 One-time Purchase Used
- 3.2 Global Automatic Insulin Dose Adjustment Software Market Size by Application
- 3.2.1 Global Automatic Insulin Dose Adjustment Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Automatic Insulin Dose Adjustment Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Automatic Insulin Dose Adjustment Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Automatic Insulin Dose Adjustment Software Market Size by Regions
- 3.3.1 North America Automatic Insulin Dose Adjustment Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Automatic Insulin Dose Adjustment Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Automatic Insulin Dose Adjustment Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Automatic Insulin Dose Adjustment Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Automatic Insulin Dose Adjustment Software Industry Trends
- 4.2 Automatic Insulin Dose Adjustment Software Industry Drivers
- 4.3 Automatic Insulin Dose Adjustment Software Industry Opportunities and Challenges
- 4.4 Automatic Insulin Dose Adjustment Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Automatic Insulin Dose Adjustment Software Revenue (2021-2026)
- 5.2 Global Automatic Insulin Dose Adjustment Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Automatic Insulin Dose Adjustment Software Key Company Headquarters & Area Served
- 5.4 Global Automatic Insulin Dose Adjustment Software Company, Product Type & Application
- 5.5 Global Automatic Insulin Dose Adjustment Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Automatic Insulin Dose Adjustment Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Automatic Insulin Dose Adjustment Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Automatic Insulin Dose Adjustment Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Glytec
- 6.1.1 Glytec Company Information
- 6.1.2 Glytec Business Overview
- 6.1.3 Glytec Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Glytec Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.1.5 Glytec Recent Developments
- 6.2 Beta Bionics
- 6.2.1 Beta Bionics Company Information
- 6.2.2 Beta Bionics Business Overview
- 6.2.3 Beta Bionics Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Beta Bionics Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.2.5 Beta Bionics Recent Developments
- 6.3 Hygieia
- 6.3.1 Hygieia Company Information
- 6.3.2 Hygieia Business Overview
- 6.3.3 Hygieia Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Hygieia Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.3.5 Hygieia Recent Developments
- 6.4 Tandem Diabetics
- 6.4.1 Tandem Diabetics Company Information
- 6.4.2 Tandem Diabetics Business Overview
- 6.4.3 Tandem Diabetics Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Tandem Diabetics Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.4.5 Tandem Diabetics Recent Developments
- 6.5 CamDiab
- 6.5.1 CamDiab Company Information
- 6.5.2 CamDiab Business Overview
- 6.5.3 CamDiab Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CamDiab Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.5.5 CamDiab Recent Developments
- 6.6 Medtronic
- 6.6.1 Medtronic Company Information
- 6.6.2 Medtronic Business Overview
- 6.6.3 Medtronic Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Medtronic Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.6.5 Medtronic Recent Developments
- 6.7 Novo Nordisk
- 6.7.1 Novo Nordisk Company Information
- 6.7.2 Novo Nordisk Business Overview
- 6.7.3 Novo Nordisk Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Novo Nordisk Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.7.5 Novo Nordisk Recent Developments
- 6.8 Omnipod
- 6.8.1 Omnipod Company Information
- 6.8.2 Omnipod Business Overview
- 6.8.3 Omnipod Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Omnipod Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.8.5 Omnipod Recent Developments
- 6.9 Tempo Platform
- 6.9.1 Tempo Platform Company Information
- 6.9.2 Tempo Platform Business Overview
- 6.9.3 Tempo Platform Automatic Insulin Dose Adjustment Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Tempo Platform Automatic Insulin Dose Adjustment Software Product Portfolio
- 6.9.5 Tempo Platform Recent Developments
7 North America
- 7.1 North America Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 7.3 North America Automatic Insulin Dose Adjustment Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 8.3 Europe Automatic Insulin Dose Adjustment Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Automatic Insulin Dose Adjustment Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 10.3 South America Automatic Insulin Dose Adjustment Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Automatic Insulin Dose Adjustment Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst